TGFB1 and Duchenne muscular dystrophy: Thus, new advances in targeting TGFβ, targeting fibrosis may prove an important strategy for DMD treatment, as there are already many approved anti-fibrotic drugs on the market that target and modulate fibrotic signaling [36,41,42].